B-cell malignancies treated with targeted drugs and sars-cov-2 infection: a european hematology association survey (epicovideha)

HIGHLIGHTS

  • who: Maria Stefania Infante from the Cairo University, Egypt Germany have published the research work: B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA), in the Journal: (JOURNAL)
  • what: This is consistent with recent data from the EPICOVIDEHA survey that described, in addition to those, other risk factors for mortality such as chronic cardiac disease, liver disease, renal impairment, smoking history, and ICU stay in a cohort of patients with various hematological malignancies.

SUMMARY

    Attempt to harness power from the patient`s . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?